Cytek Biosciences, Inc. (CTKB) Dividend History

Company News

• Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer

  Cytek Biosciences has launched the Cytek Aurora™ Evo, a new full spectrum flow cytometer that improves on its flagship Cytek Aurora system. The new system offers high-throughput and automation capabilities to meet the demands of modern research.

  GlobeNewswire Inc.
• Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025

  Cytek Biosciences, a leader in cell analysis solutions, will showcase its patented Full Spectrum Profiling technology at two prominent industry events, CYTO 2025 and IMMUNOLOGY2025. The technology is designed to streamline workflows, accelerate discoveries, and enhance efficiency in flow cytometry research and clinical studies.

  GlobeNewswire Inc.
• Advancements in Mass Cytometry (CyTOF) to Accelerate Growth of the Flow Cytometry Market for the Coming Decade, Says Future Market Insights, Inc.

  The global flow cytometry market is expected to grow from $6.38 billion in 2024 to $12.66 billion by 2034, driven by technological advancements and expanding applications. The USA, Germany, China, and India are expected to see strong growth in this market.

  GlobeNewswire Inc.

  Featured Companies: A BDX BIO BIO.B TMO
• Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program

  Cytek Biosciences, a leading cell analysis solutions company, has been named the "Overall BioTech Company of the Year" in the 2024 BioTech Breakthrough Awards program, recognizing its pioneering work in spectral flow cytometry and advancements in cell analysis tools.

  GlobeNewswire Inc.
• Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter

  Cytek Biosciences has introduced an Enhanced Small Particle (ESP) Detection Option for its Cytek Aurora CS system, enabling researchers to study and sort particles as small as 70 nm, opening new possibilities for breakthroughs in drug delivery, cell therapy, and other fields.

  GlobeNewswire Inc.